Title  |
Author |
Type |
Words |
| 1st Constitution Bancorp reports EPS 33c, consensus 41c. |
|
Financial report |
276 |
| 3M files legal actions to fight fraud, defendants had no connection to 3M. |
|
|
600 |
| Action Economics Survey results:. |
|
|
196 |
| AdvanSix sees FY20 CapEx $80M-$90M. |
|
|
204 |
| AgeX Therapeutics to lay off 12 employees. |
|
|
281 |
| Akari achieves endpoints for nomacopan in its Phase ll in BP plans nest study. |
|
|
217 |
| Akazoo appoints Michael Knott as interim CEO following termination of Zervos. |
|
|
174 |
| Akazoo says Special Committee unable to verify certain financial information. |
|
|
203 |
| Baker Hughes announces April international rig count of 915, down 144. |
|
|
156 |
| Balchem reports Q1 adjusted EPS 81c, two est. 60c. |
|
Financial report |
152 |
| Bel Fuse reports Q1 EPS (30c), one est. (30c). |
|
Financial report |
444 |
| Berry Global backs FY20 cash flow from operations view of $1.4B. |
|
|
291 |
| Berry Global reports Q2 EPS $1.19, consensus $1.07. |
|
Financial report |
394 |
| BJ's Restaurants announces $70M investment from Act III, T. Rowe Price. |
|
|
246 |
| Booking Holdings' OpenTable to waive subscription fees through end of 2020. |
|
|
200 |
| Cameco reports Q1 EPS (5c), consensus (1c). |
|
Financial report |
279 |
| Cato Corp. reopens majority of stores. |
|
|
154 |
| Chevron further reducing 2020 capital expenditure guidance by up to $2B to $14B. |
|
|
192 |
| Clorox raises FY20 EPS view to $6.70-$6.90 from $6.10-$6.25, consensus $6.57. |
|
|
423 |
| Colgate-Palmolive: FX to have mid-single digit negative impact on FY20 sales. |
|
|
157 |
| Constellation Brands exercises warrants to acquire shares in Canopy Growth. |
|
|
214 |
| Continental Materials files Form 25 in connection with plan to delist. |
|
|
287 |
| Delcath Systems prices $22M offering of stock and warrants, uplists to Nasdaq. |
|
|
187 |
| DPW Holdings announces adjournment of special meeting of stockholders. |
|
|
158 |
| Ecolab launches split-off exchange offer for Upstream Energy business. |
|
|
273 |
| Endeavour Mining, SEMAFO announce receipt of interim court order. |
|
|
278 |
| Equitrans Midstream recommends elimination of supermajority vote requirement. |
|
|
175 |
| Estee Lauder expects to reduce FY20 CapEx by ~$250M-$300M. |
|
|
332 |
| Estee Lauder not providing guidance for Q4, FY20. |
|
|
274 |
| Exxon Mobil reports Q1 EPS (14c), consensus 0c. |
|
Financial report |
170 |
| Fed's Kaplan believes the economy could contract as much as 30% annualized in Q2. |
|
|
155 |
| Fidelity D & D Bancorp completes acquisition of MNB Corporation. |
|
|
164 |
| Flexion announces publication of abstracts on patients treated with ZILRETTA. |
|
|
588 |
| Fly Intel: Top five analyst downgrades. |
|
|
245 |
| Fly Intel: Top five analyst upgrades. |
|
|
201 |
| Francesca's reports Q4 EPS (31c) vs. (13c) last year. |
|
Financial report |
215 |
| FX Update: The commodity currencies have come under pressure. |
|
|
324 |
| FX Update: The yen has outperformed. |
|
|
274 |
| Gap announces strategic licensing partnership with IMG. |
|
|
171 |
| Genmab announces FDA approval of Darzalex Faspro. |
|
|
170 |
| Gilead aims for production of at least 500K remdesivir courses by October. |
|
|
196 |
| Gilead confirms Remdesivir received FDA EUA in COVID-19 treatment. |
|
|
431 |
| GlycoMimetics reports Q1 EPS (18c), consensus (30c). |
|
Financial report |
161 |
| Greenlight exits from GM, Tempur Sealy, starts 'large' long in Change Healthcare. |
|
|
193 |
| Halozyme announces FDA approval of DARZALEX FASPRO for Janssen Biotech. |
|
|
162 |
| Hill-Rom announces initiatives in response to COVID-19 pandemic. |
|
|
421 |
| Honeywell reports Q1 EPS $2.21, consensus $1.95. |
|
Financial report |
233 |
| Honeywell suspends FY20 guidance due to COVID-19 uncertainty. |
|
|
199 |
| House Committee calls on Bezos to testify about competition concerns. |
|
|
162 |
| House Committee requests COVID-19 outbreak information from Carnival. |
|
|
296 |
| Huntsman reports Q1 adj. EPS 29c, consensus 19c. |
|
Financial report |
192 |
| ImmunoGen reports Q1 EPS (17c), consensus (15c). |
|
Financial report |
160 |
| ITC judge rules 3Shape infringed on Align Technology's scanner related patents. |
|
|
218 |
| Jerash Holdings announces factories in Jordan have resumed production. |
|
|
159 |
| Johnson Controls reports Q2 adj. EPS 42c, consensus 36c. |
|
Financial report |
265 |
| JPMorgan approved to fund about $29B to 239,000 businesses. |
|
|
155 |
| JPMorgan boosts Apple target to $350, adds to Analyst Focus List. |
|
|
163 |
| KPS Capital Partners to acquire Lufkin rod lift solutions from Baker Hughes. |
|
|
195 |
| KVH Industries reports Q1 adj. cont. ops. EPS (25c), consensus (20c). |
|
|
345 |
| Lindblad Expeditions experiences 'substantial impact' from COVID-19. |
|
|
223 |
| LyondellBasell provides business update amid COVID-19 pandemic. |
|
|
209 |
| Medigus, L1 Systems get first commercial order for COVID-19 tests. |
|
|
224 |
| MG Capital announces Egan-Jones endorsement to replace HC2 Holdings board. |
|
|
339 |
| Mobile Mini CEO says impact on operations from COVID-19 'uncertain'. |
|
|
389 |
| Moderna, Lonza announce strategic collaboration to manufacture COVID-19 vaccine. |
|
|
155 |
| Musk tweet reflects 'genuine concern' over Q2 declines, says Morgan Stanley. |
|
|
183 |
| Newell Brands announces business impact of COVID-19, actions in response. |
|
|
533 |
| Newell Brands reports Q1 normalized EPS 9c, consensus 5c. |
|
Financial report |
201 |
| Northrop Grumman awarded $123.54M Navy contract modification. |
|
|
196 |
| Olympic Steel reports Q1 EPS 5c, consensus 7c. |
|
Financial report |
173 |
| On The Fly: ETF fund flow highlights. |
|
|
200 |
| OncoCyte announces publication of long-term follow up data for DetermaRx. |
|
Clinical report |
377 |
| PG&E reports Q1 core EPS 89c, consensus $1.02. |
|
Financial report |
176 |
| Phillips 66 Partners provides strategic update amid COVID-19 pandemic. |
|
|
274 |
| Phillips 66 reports Q1 adj. EPS $1.02, consensus $2.59. |
|
Financial report |
250 |
| Phillips 66 reports Q1 adj. EPS $1.02, consensus 62c. |
|
Financial report |
250 |
| Phillips 66 urges shareholders to reject TRC's 'mini-tender' offer. |
|
|
156 |
| Playa Hotels & Resorts to sell Jewel Dunn's Beach Resort, Jewel Runaway resort. |
|
|
193 |
| Power REIT expands cannabis greenhouse property in Colorado. |
|
|
156 |
| Primoris announces solar awards valued $50M. |
|
|
189 |
| Quotient announces CE Mark for SARS-CoV-2 antibody microarray. |
|
|
179 |
| RBS sees FY20 impairment loss meaningfully higher than prior guidance. |
|
|
169 |
| Restaurant Brands reports Q1 adjusted EPS 48c, consensus 56c. |
|
Financial report |
196 |
| Restaurant Brands sees more significant impact from COVID-19 in Q2 than in Q1. |
|
|
195 |
| Revance continues Botox program discussions with Mylan. |
|
|
166 |
| Sabre, Farelogix agree to terminate merger agreement. |
|
|
159 |
| So-Young appoints Chao He, Harry Jiannan Wang to board of directors. |
|
|
386 |
| Sotherly Hotels implements cost control measures. |
|
|
399 |
| Southwest announces modified boarding procedures, mask policies. |
|
|
240 |
| SPI Energy receives Nasdaq noice of noncompliance. |
|
|
181 |
| Spirit AeroSystems to lay off 1,450 employees at Wichita, KS plant. |
|
|
152 |
| TC Energy reports Q1 comparable EPS C$1.18, consensus C$1.06. |
|
Financial report |
316 |
| Teva announces new Ajovy, Austedo data published. |
|
|
209 |
| TG Therapeutics announces publication from trial evaluating ublituximab. |
|
|
315 |
| The U.S. construction spending report. |
|
|
225 |
| The U.S. ISM. |
|
|
213 |
| Tix Corp reports Q1 EPS (5c) vs. 0c last year. |
|
Financial report |
324 |
| TravelCenters reduces corporate headcount by 130, announces reorganization. |
|
|
204 |
| Treasury Market Outlook: risk aversion picked up overnight. |
|
|
174 |
| Treasury Market Summary. |
|
|
197 |
| Twin Disc reports Q3 EPS ($1.92), two est. (11c). |
|
Financial report |
465 |
| Tyson Foods to resume limited production at Logansport, Ind. facility next week. |
|
|
310 |
| U.S. equity futures are weaker. |
|
|
198 |
| U.S. Silica reports Q1 EPS (98c), consensus (43c). |
|
Financial report |
273 |
| U.S. Silica sees Q2 Oil & Gas segment sales down 'sharply'. |
|
|
166 |
| VIVUS announces agreement with IEH Biopharma on grace period to restructure debt. |
|
|
158 |
| Weyerhaeuser reports Q1 EPS 20c, consensus 13c. |
|
Financial report |
239 |
| Weyerhaeuser sees Q2 Timberlands earnings, adj. EBITDA 'significantly lower'. |
|
Financial report |
454 |
| Weyerhaeuser temporarily suspending quarterly dividend. |
|
|
377 |
| Williams-Sonoma extends temporary U.S., Canada store closures until May 17. |
|
|
192 |
| WillScot reports Q1 EPS (3c), consensus 8c. |
|
Financial report |
176 |
| XBiotech identifies 'super bloods' for True Human COVID-19 therapy development. |
|
|
187 |
May 1, 2020
